Baker Avenue Asset Management’s iShares US Medical Devices ETF IHI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$12.1M Buy
226,743
+11,547
+5% +$678K 0.27% 81
2025
Q4
$13.4M Buy
215,196
+21,988
+11% +$1.36M 0.31% 74
2025
Q3
$11.6M Sell
193,208
-23,224
-11% -$1.42M 0.28% 81
2025
Q2
$13.6M Buy
216,432
+49,387
+30% +$2.97M 0.39% 66
2025
Q1
$10.1M Buy
167,045
+2,792
+2% +$173K 0.31% 71
2024
Q4
$9.58M Buy
164,253
+2,901
+2% +$172K 0.29% 69
2024
Q3
$9.56M Buy
161,352
+2,970
+2% +$170K 0.3% 67
2024
Q2
$8.88M Sell
158,382
-2,168
-1% -$121K 0.3% 69
2024
Q1
$9.41M Buy
160,550
+10,263
+7% +$580K 0.37% 63
2023
Q4
$8.11M Buy
150,287
+8,130
+6% +$397K 0.36% 63
2023
Q3
$6.89M Buy
142,157
+2,347
+2% +$125K 0.35% 65
2023
Q2
$7.89M Sell
139,810
-1,295
-0.9% -$71.3K 0.4% 59
2023
Q1
$7.62M Sell
141,105
-754
-0.5% -$40.1K 0.41% 61
2022
Q4
$7.46M Buy
141,859
+3,026
+2% +$154K 0.45% 58
2022
Q3
$6.55M Buy
138,833
+1,469
+1% +$76.2K 0.41% 66
2022
Q2
$6.93M Buy
137,364
+1,739
+1% +$94.8K 0.46% 60
2022
Q1
$8.27M Buy
135,625
+4,737
+4% +$282K 0.42% 63
2021
Q4
$8.62M Buy
130,888
+7,720
+6% +$494K 0.43% 64
2021
Q3
$7.73M Buy
123,168
+4,158
+3% +$265K 0.44% 61
2021
Q2
$7.16M Buy
119,010
+5,820
+5% +$337K 0.41% 64
2021
Q1
$6.23M Buy
113,190
+1,446
+1% +$80.2K 0.38% 64
2020
Q4
$6.09M Buy
111,744
+498
+0.4% +$26K 0.42% 60
2020
Q3
$5.55M Sell
111,246
-9,666
-8% -$468K 0.43% 50
2020
Q2
$5.34M Buy
120,912
+6,012
+5% +$257K 0.44% 51
2020
Q1
$4.32M Buy
114,900
+3,402
+3% +$143K 0.51% 36
2019
Q4
$4.91M Sell
111,498
-15,582
-12% -$655K 0.36% 72
2019
Q3
$5.24M Sell
127,080
-1,956
-2% -$80.1K 0.42% 64
2019
Q2
$5.18M Sell
129,036
-28,446
-18% -$1.08M 0.42% 62
2019
Q1
$6.08M Buy
157,482
+7,098
+5% +$258K 0.5% 56
2018
Q4
$5.01M Buy
150,384
+2,832
+2% +$98.1K 0.49% 57
2018
Q3
$5.59M Sell
147,552
-1,368
-0.9% -$48.6K 0.46% 61
2018
Q2
$4.98M Sell
148,920
-3,234
-2% -$105K 0.43% 62
2018
Q1
$4.69M Buy
152,154
+3,270
+2% +$101K 0.43% 61
2017
Q4
$4.3M Sell
148,884
-2,562
-2% -$73.9K 0.42% 63
2017
Q3
$4.22M Sell
151,446
-4,014
-3% -$111K 0.47% 57
2017
Q2
$4.32M Buy
155,460
+1,626
+1% +$43.1K 0.57% 51
2017
Q1
$3.88M Buy
153,834
+5,970
+4% +$145K 0.52% 55
2016
Q4
$3.28M Sell
147,864
-28,380
-16% -$644K 0.46% 59
2016
Q3
$4.27M Sell
176,244
-28,428
-14% -$676K 0.61% 51
2016
Q2
$4.62M Sell
204,672
-47,784
-19% -$1.03M 0.7% 47
2016
Q1
$5.15M Sell
252,456
-41,772
-14% -$811K 0.78% 41
2015
Q4
$6.01M Buy
294,228
+27,978
+11% +$560K 0.86% 28
2015
Q3
$4.94M Buy
266,250
+1,080
+0.4% +$21.7K 0.87% 29
2015
Q2
$5.29M Sell
265,170
-9,012
-3% -$180K 0.7% 28
2015
Q1
$5.5M Buy
274,182
+8,040
+3% +$157K 0.73% 28
2014
Q4
$5.02M Buy
266,142
+13,998
+6% +$253K 0.7% 32
2014
Q3
$4.18M Buy
252,144
+51,666
+26% +$879K 0.58% 41
2014
Q2
$3.41M Buy
200,478
+31,446
+19% +$514K 0.49% 60
2014
Q1
$2.78M Buy
169,032
+33,126
+24% +$531K 0.47% 73
2013
Q4
$2.1M Buy
+135,906
New +$2.03M 0.4% 63

Other funds holding IHI

Baker Avenue Asset Management's IHI Position: Q1 2026 in Review

Baker Avenue Asset Management increased its iShares US Medical Devices ETF (IHI) stake by 5.4% in Q1 2026, buying an estimated $678K and bringing the position to 226,743 shares worth $12.1M. The position accounts for 0.27% of the portfolio, ranked #81.

Baker Avenue Asset Management first reported a position in IHI in Q4 2013 and has held it in 50 quarters since. The position peaked at $13.6M in Q2 2025. 503 funds tracked by Wall St. Rank hold IHI as of Q1 2026.

  • Baker Avenue Asset Management held 226,743 shares of iShares US Medical Devices ETF worth $12.1M as of Q1 2026.
  • Baker Avenue Asset Management bought 11,547 iShares US Medical Devices ETF shares in Q1 2026, an estimated $678K.
  • iShares US Medical Devices ETF made up 0.27% of Baker Avenue Asset Management's portfolio in Q1 2026, its #81 holding.
  • Baker Avenue Asset Management first reported a position in iShares US Medical Devices ETF in Q4 2013 and has held it in 50 quarters since.
  • Baker Avenue Asset Management's iShares US Medical Devices ETF position peaked at $13.6M in Q2 2025.
  • 503 funds tracked by Wall St. Rank held iShares US Medical Devices ETF as of Q1 2026.

Based on Baker Avenue Asset Management's 13F filing for Q1 2026, filed 12 May 2026.